Optimal end point of FR167653 administration and expression of interleukin-8 messenger RNA on extended liver resection with ischemia in dogs 1 1 No competing interests declared. 2 2 Fujisawa Pharmaceutical Co Ltd provided Gunma University with research funds.
Titel:
Optimal end point of FR167653 administration and expression of interleukin-8 messenger RNA on extended liver resection with ischemia in dogs 1 1 No competing interests declared. 2 2 Fujisawa Pharmaceutical Co Ltd provided Gunma University with research funds.